Jaksch W, Messerer B, Keck B, Lischka A, Urlesberger B
Abteilung für Anästhesie, Intensiv- und Schmerzmedizin, Wilhelminenspital der Stadt Wien, Wien, Österreich.
Schmerz. 2014 Feb;28(1):25-30. doi: 10.1007/s00482-014-1389-3.
The false assumption that neonates are less sensitive to pain than adults led to a long delay in the introduction of a reasonable pain therapy for children. Even if the basic principles of the development, transmission and perception of pain in premature infants and neonates are not completely understood, the results of studies have clearly shown that pain can be perceived from 22 weeks of gestation onwards. This knowledge results in the necessity to also administer an adequate pain therapy to premature and newly born infants. However, for the use of pharmaceuticals in neonates and infants the pharmacodynamic and pharmacokinetic characteristics must also be considered. The immaturity of the organs liver and kidneys limits the metabolism and also excretion processes. The different physical proportions also modify the dosing of pharmaceuticals. Children in the first year of life differ substantially from adults in physiology, pharmacodynamics and pharmacokinetics. The care of neonates and infants requires specialist knowledge which is described in this article.
认为新生儿对疼痛的敏感度低于成人的错误假设导致了为儿童引入合理疼痛治疗的长期延迟。即使早产婴儿和新生儿疼痛的发生、传导和感知的基本原理尚未完全明了,但研究结果已清楚表明,从妊娠22周起就能感知疼痛。这一认知使得有必要对早产和新生婴儿也进行适当的疼痛治疗。然而,对于在新生儿和婴儿中使用药物,还必须考虑其药效学和药代动力学特性。肝脏和肾脏器官的不成熟限制了代谢以及排泄过程。不同的身体比例也会改变药物剂量。一岁以内的儿童在生理学、药效学和药代动力学方面与成人有很大差异。对新生儿和婴儿的护理需要本文所描述的专业知识。